Trials / Conditions / Chronic Immune Thrombocytopenia
Chronic Immune Thrombocytopenia
3 registered clinical trials studyying Chronic Immune Thrombocytopenia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP) NCT06665308 | Sanofi | — |
| Recruiting | A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adu NCT07017725 | CASI Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Terminated | Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopeni NCT03866798 | Octapharma | Phase 4 |